Hypertension Diagnostics Buy Hold or Sell Recommendation

HDIIDelisted Stock  USD 0  0.0008  38.10%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Hypertension Diagnostics is 'Not Rated'. Macroaxis provides Hypertension Diagnostics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HDII positions. The advice algorithm takes into account all of Hypertension Diagnostics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Hypertension Diagnostics' buy or sell advice are summarized below:
Real Value
0.002768
Hype Value
0.003625
Market Value
0.0029
Naive Value
0.001735
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Hypertension Diagnostics given historical horizon and risk tolerance towards Hypertension Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for Hypertension Diagnostics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
In addition, we conduct extensive research on individual companies such as Hypertension and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Hypertension Diagnostics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Hypertension Diagnostics Buy or Sell Advice

The Hypertension recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hypertension Diagnostics. Macroaxis does not own or have any residual interests in Hypertension Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hypertension Diagnostics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Hypertension DiagnosticsBuy Hypertension Diagnostics
Not Rated
For the selected time horizon Hypertension Diagnostics has a Risk Adjusted Performance of 0.0683, Jensen Alpha of 1.74, Total Risk Alpha of 0.2487, Sortino Ratio of 0.0716 and Treynor Ratio of (0.21)
We provide advice to complement the regular expert consensus on Hypertension Diagnostics. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Hypertension Diagnostics is not overpriced, please check out all Hypertension Diagnostics fundamentals, including its net income, beta, net asset, as well as the relationship between the book value per share and working capital . As Hypertension Diagnostics appears to be a penny stock we also urge to confirm its price to sales numbers.

Hypertension Diagnostics Trading Alerts and Improvement Suggestions

Hypertension Diagnostics is not yet fully synchronised with the market data
Hypertension Diagnostics has some characteristics of a very speculative penny stock
Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years
The company currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K.
Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations.

Hypertension Diagnostics Returns Distribution Density

The distribution of Hypertension Diagnostics' historical returns is an attempt to chart the uncertainty of Hypertension Diagnostics' future price movements. The chart of the probability distribution of Hypertension Diagnostics daily returns describes the distribution of returns around its average expected value. We use Hypertension Diagnostics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hypertension Diagnostics returns is essential to provide solid investment advice for Hypertension Diagnostics.
Mean Return
1.43
Value At Risk
-23.33
Potential Upside
34.78
Standard Deviation
15.36
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hypertension Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Hypertension Diagnostics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hypertension . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Hypertension Diagnostics Buy or Sell Advice

When is the right time to buy or sell Hypertension Diagnostics? Buying financial instruments such as Hypertension Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Hypertension Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Conservative Funds Thematic Idea Now

Conservative Funds
Conservative Funds Theme
Funds or Etfs that invest using buy-and-hold investment strategy in companies with consistent growth over many years of operation. The Conservative Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Conservative Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Hypertension Pink Sheet

If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios